Over 7,000 Volunteers Recruited in Q1 This Year!

Posted:
7
June 2004

Richmond Pharmacology is delighted to announce we recruited over 7,000 new volunteers between January and March of 2004. This takes the total number of volunteers registered to over 25,000 in just 2 years.Quarter two looks set to yield similar recruitment figures, with over 2,300 new volunteers registering every month. The result is a testimony to Richmond Pharmacology’s dedicated volunteer recruitment team:Wendy Galloway, Head of Volunteer Recruitment, commented: “Obviously the whole team is delighted with the results of our recruitment programme. Our wide ranging advertising campaigns are drawing in thousands of enquiries to our recruitment website www.trials4us.co.uk and our telerecruitment team. Richmond Pharmacology is conducting an ever growing number of studies, which puts the onus on successful, targeted volunteer recruitment. It means we are able to guarantee delivery of whatever type of volunteer panel our clients require. I look forward to continuing to grow our volunteer database at such a fast rate.”

Latest news

Upcoming Event

EUFEMED, 3rd Annual Conference, 28-30 April 2021

28-30 April 2021
Dr Jorg Taubel will co-chair a session on day one, which explores how technology has reduced the risks of pandemic effects on Phase I and II trial performance.
View event

Richmond Pharmacology listed in the Alantra Pharma Fast 50

July 13, 2021
Richmond has been included in a top 50 list of the UK’s fastest-growing, privately-owned pharmaceutical businesses. 
Read more

Richmond Pharmacology listed in the J.P. Morgan Top 200 Female Powered Businesses

June 29, 2021
J.P. Morgan has identified Richmond Pharmacology as a high-growth female-powered business in its annual 'Top 200 Female Powered Businesses' list 2021.
Read more

CRISPR-Cas9 in-vivo gene editing shows reduction in TTR after a single dose

June 29, 2021
Data produced through Intellia Therapeutic’s NTLA-2001 FIH clinical trial, conducted at Richmond Pharmacology, indicates a reduction in the faulty TTR protein after a single infusion. Results were presented by Professor Julian Gillmore at this year’s Peripheral Nerve Society Annual Meeting.
Read more